Asian press release distribution

Press Releases for Tuesday, March 14, 2023

Prenetics公布2022年第四季度及全年财务业绩新业务策略专注于精准肿瘤学 22:07 HKT/SGT

Prenetics公布2022年第四季度及全年財務業績新業務策略專注於精準腫瘤學 22:06 HKT/SGT

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology 22:05 HKT/SGT

NFT-TiX Secures VIP Lounge Naming Rights for Hardmission and Techmission Festival Prague 2023 21:01 HKT/SGT

富通保险推出限时震撼优惠预缴全期保费可享保证5%年利率 16:32 HKT/SGT

富通保險推出限時震撼優惠預繳全期保費可享保證5%年利率 16:31 HKT/SGT

日立・京都大学・リバーセルが、他家T細胞療法の普及に向け、自動培養技術開発のための共同研究契約を締結 16:00 HKT/SGT

Think Equity: Society Pass (Nasdaq: SOPA) - Path to Profitability 14:00 HKT/SGT

中国通海金融委任旗下中国通海资产管理行政总裁 12:32 HKT/SGT

中國通海金融委任旗下中國通海資產管理行政總裁 12:31 HKT/SGT

Tonghai Financial Announces Appointment of Christopher Tang to CEO of China Tonghai Asset Management 12:30 HKT/SGT

中国通海金融宣布委任旗下中国通海企业融资（控股）联席主席 12:29 HKT/SGT

中國通海金融宣布委任旗下中國通海企業融資（控股）聯席主席 12:28 HKT/SGT

Tonghai Financial Announces Appointment of Ambrose Lam as Co-Chairman of China Tonghai Capital (Holdings) Limited 12:27 HKT/SGT

亞洲聯合基建簽訂11億港元三年期之定期貸款協議 11:22 HKT/SGT

Asia Allied Infrastructure Concludes HK$1.1 Billion 3-Year Term Loan Agreement 11:21 HKT/SGT

U.S. Veterans' Health Administration (VHA) Provides Coverage of LEQEMBI (lecanemab-Irmb) Two Months After LEQEMBI's FDA Accelerated Approval for Veterans Living with Early Stages of Alzheimer's Disease 10:09 HKT/SGT

ソニー、「2023 World's Most Ethical Companies（世界で最も倫理的な企業）」の1社に選定 09:30 HKT/SGT

エーザイ、早期アルツハイマー病治療薬「LEQEMBI(TM)」（レカネマブ）について、米国退役軍人保健局が FDA による迅速承認から 2 カ月で保険適用を開始 09:30 HKT/SGT

ADEC Innovations 收購 Kedge Pty Ltd 和 Southern Ocean Carbon Company 06:21 HKT/SGT

ADEC Innovations 收购 Kedge Pty Ltd 和 Southern Ocean Carbon Company 06:21 HKT/SGT

ADEC Innovations Acquires Kedge Pty Ltd and Southern Ocean Carbon Company 06:21 HKT/SGT

ACN Search:

Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575